![Martin Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Evans
Gründer bei
Celixir Plc
Vermögen: 2 Mio $ am 31.12.2025
Profil
Martin John Evans is the founder of Oncogeni Ltd. founded in 2019, holding the title of Director since 2022.
Dr. Evans was the founder of Cell Therapy Ltd. founded in 2009, holding the titles of President & Chief Scientific Officer from 2015 to 2018.
Dr. Evans is the founder of Cardiogeni Plc founded in 2016, holding the titles of Director & Chief Scientific Officer since 2016.
Former jobs include Non-Executive Director at Coiled Therapeutics Plc from 2024 to 2025 and President at the University of Cardiff.
Education history includes a doctorate from University College London conferred in 1969 and an undergraduate degree from Christ's College (United Kingdom) conferred in 1963.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Celixir Plc
 Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases 18.92% | 21.04.2026 | 16’855’254 ( 18.92% ) | 2 Mio $ | 31.12.2025 |
| 03.12.2024 | 269 ( 0% ) | 35 $ | 31.07.2026 |
Aktive Positionen von Martin Evans
| Unternehmen | Position | Beginn |
|---|---|---|
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Gründer | 28.12.2016 |
Oncogeni Ltd.
 Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Gründer | 01.05.2019 |
Ehemalige bekannte Positionen von Martin Evans
| Unternehmen | Position | Ende |
|---|---|---|
| ROQT THER | Technik-/Wissenschafts-/F&E-Leiter | 23.05.2024 |
University of Cardiff
 University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Präsident | - |
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Gründer | - |
Ausbildung von Martin Evans
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
Christ's College (United Kingdom)
 Christ's College (United Kingdom) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Health Technology |
Roquefort Therapeutics Plc
 Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
